Biomarkers in Breast Cancer / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$194.84
Used and New from Other Sellers
Used and New from Other Sellers
from $30.00
Usually ships in 1-2 business days
(Save 89%)
Other sellers (Hardcover)
  • All (16) from $30.00   
  • New (10) from $54.13   
  • Used (6) from $30.00   

Overview

Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.

Read More Show Less

Editorial Reviews

From The Critics
Reviewer: Mary E. Cianfrocca, DO (Northwestern University Feinberg School of Medicine)
Description: This is an overview of the major predictive and prognostic biomarkers in breast cancer.
Purpose: The objectives of the book, to review the major advances in the application of molecular methodology as well as the state-of-the-art of conventional prognostic and predictive biomarkers in breast cancer, were met. These are very worthy objectives as this is a rapidly advancing field that has the potential to drastically change the way we approach the treatment of breast cancer in the future.
Audience: The editors intended the book to be used by laboratory and clinical investigators, but it is also a useful review of the subject for clinicians. The editors and contributors are all credible authorities in the field.
Features: The first three chapters cover study design and guidelines for validation studies of new biomarkers while the next two chapters cover gene expression profiling with DNA microarrays and assays for gene amplification. Subsequent chapters cover individual biomarkers in detail. The chapters are well written and comprehensive. Chapters on erb-B2, for example, provide a detailed examination of the predictive value of this marker as well as its usefulness as a therapeutic target.
Assessment: This book will be very useful to the intended target population of researchers as well as to a broader audience. The use of biomarkers in breast cancer shows great promise in significantly influencing our future treatment of breast cancer. A well-written review of the topic such as this one would therefore also be very valuable to clinicians and physicians in training.

4 Stars! from Doody
Read More Show Less

Product Details

  • ISBN-13: 9781588292278
  • Publisher: Springer-Verlag New York, LLC
  • Publication date: 10/1/2005
  • Series: Cancer Drug Discovery and Development Series
  • Edition description: 2006
  • Edition number: 1
  • Pages: 342
  • Product dimensions: 9.21 (w) x 6.14 (h) x 0.81 (d)

Table of Contents

Part I. General Topics

Guidelines for the Design of Clinical Studies for the Development and Validation of Therapeutically Relevant Biomarkers and Biomarker-Based Classification Systems

Richard M. Simon

Analytical Aspects of Biomarker Immunoassays in Cancer Research

Fred C. G. J. Sweep, Chris M. G. Thomas, and Manfred Schmitt

Tissue Microarrays: State of the Art, Pitfalls, and Promises

Chungyeul Kim and Soonmyung Paik

Part II. Assays for Gene Expression and Post-Translational Protein Abnormalities

Gene Expression Profiling with DNA Microarrays: Revolutionary Tools to Help Diagnosis, Prognosis, Treatment Guidance, and Drug Discovery

Michele De Bortoli and Nicoletta Biglia

Part III. Assays for DNA Abnormalities

Assays for Gene Amplification: State of the Art, Pitfalls, and Promises

Chungyeul Kim, Yongkuk Song, and Soonmyung Paik

Part IV. Tissue Predictive Biomarkers

Cell Kinetics

Maria Grazia Daidone, Rosella Silvestrini, and Dino Amadori

Urokinase-Type Plasminogen Activator and PAI-1: Validated Prognostic Factors for Breast Cancer

Michael J. Duffy

Predictive Value of c-erb-B2 for Endocrine Therapy and Chemotherapy in Breast Cancer

Vered Stearns

erb-B2 as a Therapeutic Target

Robert Mass

The Epidermal Growth Factor Receptor Pathway as a Selective Molecular-Targeted Treatment in Human Breast Cancer

Fortunato Ciardiello, Teresa Troiani, and Giampaolo Tortora

p53 as a Prognostic and Predictive Indicator

Daniela Kandioler and Raimund Jakesz

Part V. Predictive Biomarkers in Body Fluids

Occult Metastatic Cells in Breast Cancer Patients: State of the Art, Pitfalls, and Promises

Stephan Braun, Julia Seeber, and Christian Marth

Circulating HER2/neu: Clinical Utility

Allan Lipton, Laurence Demers, Kim Leitzel, Suhail M. Ali, Rainer Neumann, Christopher P. Price, and Walter P. Carney

Circulating Vascular Endothelial Growth Factor: Methods, Prognostic Significance, and Potential Application for Antiangiogenic Therapy

Roberta Sarmiento, Roberta Franceschini, Sabrina Meo, Massimo Gion, Raffele Longo, and Giampietro Gasparini

Detection of Early Tumor Dissemination in Patients with Breast Cancer

Debra Hawes and Richard J. Cote

Part VI. Future Directions

New Technologies/New Markers/New Challenges

Daniel F. Hayes and Giampietro Gasparini

Index

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)